Newsroom

Industry News

16 Apr

MTNB: Matinas’ Pipeline Is Ready To Shine

Matinas (MTNB) announced the establishment of a lipid-based, anti-infective platform with the acquisition of Aquarius BioTechnologies, Inc. This was the Bioral™ technology previously owned by BioDelivery Sciences International (BDSI) from 2002 to 2009. BioDelivery was unable to move forward with the technology because sourcing the key raw material to create the...

Read more

16 Apr

Harvard Apparatus Regenerative Technology Reports CEO Transition

Conference Call To Be Held at 5:00 PM ET Today Harvard Apparatus Regenerative Technology, Inc. (Nasdaq: HART), or HART, a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, reports that David Green has resigned as Chief Executive Officer, President and Chairman of the...

Read more

16 Apr

Eco-Shift Power Corp. (OTCQB: ECOP) Has Secured the Development Phase of a 38 Site Project in Washington State for a National Retail Customer

Eco-Shift Power Corp (ECOP) – ECOP’s wholly-owned subsidiary, Sun & Sun Industries Inc. (“Sun Industries”), has secured the development phase of a 38 site project scheduled to begin this quarter in Washington State. This project commences, while a statewide rollout of turnkey energy efficient lighting projects in Utah and Wyoming beginning...

Read more

16 Apr

Relmada Therapeutics Receives Health Canada Clearance to Further Explore Promising NMDA Receptor Antagonist d-Methadone (REL-1017)

Phase 1 study to include additional cohorts with novel product candidate being developed for the treatment of neuropathic pain Relmada Therapeutics, Inc. (RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has received clearance from Health Canada to continue dose escalation...

Read more

Page 1 of 6212345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets